Mario Barro

Mario is a Director of Innovation, Vaccines at RA Capital. Mario has more than two decades of experience in vaccinology, virology and immunology research in large pharma, government, academy and biotech settings. Prior to joining RA Capital, Mario was Associate Vice President for Advanced Research at Sanofi Pasteur where he created and executed a novel integrative strategy for influenza vaccine development including Machine Learning, Automation, High Through Put, Antigen Design, Translational Models, Data Viz, Scrum Agile and New CMC Platforms.